Cryptotanshinone at 6 and 18 mg/kg (p.o., for 16 days) in type II collagen-induced arthritis in female Wistar rats, and 5 and 20 μM concentration inhibits the degradation of NF-κB (IκB)-α blocker [71]. This evidence concerns the gene NFKB1 and arthritic joint disease.